1. Corrigendum to "PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1" [Cancer Letters 375 (1) (2016 May 28) 190–198]. (1st September 2022) Authors: Li, Qing; Liu, Zhikui; Xu, Meng; Xue, Yumo; Yao, Bowen; Dou, Changwei; Jia, Yuli; Wang, Yufeng; Tu, Kangsheng; Zheng, Xin; Yao, Yingmin Journal: Cancer letters Issue: Volume 543(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lymphocyte‐specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation. Issue 12 (7th November 2016) Authors: Zhang, Hongyong; Wang, Yufeng; Liu, Zhikui; Yao, Bowen; Dou, Changwei; Xu, Meng; Li, Qing; Jia, Yuli; Wu, Shengli; Tu, Kangsheng; Liu, Qingguang Journal: FEBS open bio Issue: Volume 6:Issue 12(2016) Page Start: 1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MiR-187-3p inhibits the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by targeting S100A4. Issue 2 (28th October 2016) Authors: Dou, Changwei; Liu, Zhikui; Xu, Meng; Jia, Yuli; Wang, Yufeng; Li, Qing; Yang, Wei; Zheng, Xin; Tu, Kangsheng; Liu, Qingguang Journal: Cancer letters Issue: Volume 381:Issue 2(2016) Page Start: 380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1. Issue 1 (28th May 2016) Authors: Li, Qing; Liu, Zhikui; Xu, Meng; Xue, Yumo; Yao, Bowen; Dou, Changwei; Jia, Yuli; Wang, Yufeng; Tu, Kangsheng; Zheng, Xin; Yao, Yingmin Journal: Cancer letters Issue: Volume 375:Issue 1(2016) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗